What is Cormark’s Estimate for OTC:GTBIF FY2024 Earnings?

Green Thumb Industries Inc. (OTC:GTBIF) – Stock analysts at Cormark dropped their FY2024 EPS estimates for shares of Green Thumb Industries in a note issued to investors on Monday, November 11th. Cormark analyst J. Pytlak now expects that the company will post earnings of $0.33 per share for the year, down from their previous estimate of $0.38. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.32 per share. Cormark also issued estimates for Green Thumb Industries’ FY2025 earnings at $0.40 EPS.

Several other research analysts have also commented on GTBIF. Ventum Cap Mkts upgraded Green Thumb Industries to a “strong-buy” rating in a research report on Tuesday, August 6th. Craig Hallum raised Green Thumb Industries to a “strong-buy” rating in a research note on Monday, September 16th. Finally, Roth Capital upgraded shares of Green Thumb Industries to a “strong-buy” rating in a research report on Sunday, November 10th.

Green Thumb Industries Price Performance

Green Thumb Industries stock opened at $9.29 on Wednesday. The stock has a market cap of $1.97 billion, a P/E ratio of 34.42 and a beta of 1.40. Green Thumb Industries has a 12-month low of $7.50 and a 12-month high of $16.33. The business’s fifty day moving average price is $10.24.

About Green Thumb Industries

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.